25 results
PRE 14A
TRDA
Entrada Therapeutics Inc
19 Apr 24
Preliminary proxy
7:00am
competitive within the marketplace. During 2023, each of Mr. Doshi, Dr. Sethuraman and Mr. Dowden were entitled to receive a target bonus of 55%, 40% and 40 … % of their base salary, respectively. The bonus was calculated on a pro-rata basis accordingly. Based on our achievement of the applicable performance
8-K
TRDA
Entrada Therapeutics Inc
3 Jan 24
Departure of Directors or Certain Officers
7:16am
year, with a target bonus percentage of 45%, in each case effective as the Effective Date. Mr. Dowden was also granted 60,000 restricted stock units
8-K
EX-1.1
wcg kltb1tevaatbflk
29 Sep 23
Entry into a Material Definitive Agreement
4:39pm
DEF 14A
lotqp3yvoc
19 Apr 22
Definitive proxy
4:13pm
10-K
1hl3pk
15 Mar 22
Annual report
7:49am
10-Q
h21dtx rhm6
9 Dec 21
Quarterly report
4:03pm
424B4
i6ybdtl zdsr6ir4
1 Nov 21
Prospectus supplement with pricing info
4:02pm
S-1/A
jjyabq
25 Oct 21
IPO registration (amended)
6:05am
S-1/A
EX-10.10
k6an3xv04x k7zacc4ru
25 Oct 21
IPO registration (amended)
6:05am
S-1/A
EX-10.7
olabxtpa1nf25yfp
25 Oct 21
IPO registration (amended)
6:05am
S-1/A
EX-10.11
6qj5vfa2t efbdf
25 Oct 21
IPO registration (amended)
6:05am
S-1/A
EX-10.6
viaqvy4a iz8c0
25 Oct 21
IPO registration (amended)
6:05am
S-1/A
EX-10.5
yrrlc448v 9ipsfe
25 Oct 21
IPO registration (amended)
6:05am
S-1/A
EX-10.9
ua2h5xx hesz5l
25 Oct 21
IPO registration (amended)
6:05am
S-1
092wojhwh qq3qu4
8 Oct 21
IPO registration
5:00pm